Effects and side-effects of glaucoma medication: an overview

被引：0

作者：

Kuess, W. ^{[1
]}

Wimpissinger, B. ^{[1
]}

机构：

[1] KA Rudolfstiftung, Augenabt, A-1030 Vienna, Austria

来源：

SPEKTRUM DER AUGENHEILKUNDE | 2008年 / 22卷 / 04期

关键词：

Glaucoma; medical therapy; side effects;

D O I：

10.1007/s00717-008-0270-0

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Over the past years ophthalmologists were provided with an increasing number of medical glaucoma therapies. On the one hand the therapeutic spectrum is broadened, but on the other hand we are faced with further local and systemic side effects. This article overviews commonly used medication in glaucoma and focuses on possible side effects.

引用

页码：233 / 236

页数：4

共 16 条

[1] Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning - A comparison with timolol [J].

Alm, A ;

Stjernschantz, J ;

Widengard, I ;

Linden, C ;

Soderstrom, M ;

Nilsson, SE ;

Fristrom, B ;

Lindblom, B ;

Heijl, A ;

Gundersen, KG ;

Ehinger, B ;

Holmin, C ;

BengtssonStigmar, E ;

Aasved, H ;

Jangard, P ;

Ringvold, A ;

Vegge, T ;

Halseide, R ;

LundAndersen, H ;

Flesner, P ;

Thygesen, J ;

Airaksinen, J ;

Tuulonen, A .

OPHTHALMOLOGY, 1995, 102 (12) :1743-1752

[2] The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulation [J].

Arend, O ;

Harris, A ;

Arend, S ;

Remky, A ;

Martin, BJ .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 1998, 76 (01) :43-49

[3] Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients [J].

Arend, O ;

Harris, A ;

Wolter, P ;

Remky, A .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (05) :474-479

[4] Comparison of the efficacy of the fixed-combination timolol/dorzolamide versus concomitant administration of timolol and dorzolamide [J].

Bacharach, J ;

Delgado, MF ;

Iwach, AG .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2003, 19 (02) :93-96

[5] Latanoprost, a prostaglandin analog, for glaucoma therapy - Efficacy and safety after 1 year of treatment in 198 patients [J].

Camras, CB ;

Alm, A ;

Watson, P ;

Stjernschantz, J ;

Aasved, H ;

Jangard, P ;

LundAndersen, H ;

Flesner, P ;

Soderstrom, M ;

Ehinger, B ;

Holmin, C ;

BengtssonStigmar, E ;

Heijl, A ;

Gundersen, KG ;

Airaksinen, J ;

Tuulonen, A ;

Halseide, R ;

Lindblom, B ;

Ringvold, A ;

Vegge, T ;

Linden, C ;

Nilsson, SE ;

Fristrom, B ;

Widengard, I ;

Thygesen, J ;

Green, F ;

Valenzuela, F ;

Potts, M ;

Spencer, I ;

Coakes, R ;

Reynolds, P ;

Mills, B ;

Chatterjee, A ;

Nagasubramanian, S ;

Roxburgh, S ;

Sanders, R ;

Bailey, M ;

Whyte, IF ;

Vernon, S ;

Sloper, M ;

Murray, S ;

Davey, C ;

HickmanCasey, J ;

Longstaff, S ;

Currie, Z ;

Wishart, P ;

Austin, M ;

Birch, M ;

Elkington, A ;

Luff, A .

OPHTHALMOLOGY, 1996, 103 (11) :1916-1924

[6] Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management [J].

Cantor, LB .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (04) :721-731

[7]

Chew SJ, 1997, J GLAUCOMA, V6, P263

[8]

FENTON S, 1998, SEARCH GLAUCOMA, V6, P34

[9]

GERSTE RD, 1998, OPHTHALMOLOGY, V2, P17

[10] Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension [J].

Netland, PA ;

Landry, T ;

Sullivan, EK ;

Andrew, R ;

Silver, L ;

Weiner, A ;

Mallick, S ;

Dickerson, J ;

Bergamini, MVW ;

Robertson, SM ;

Davis, AA .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (04) :472-484

← 1 2 →